Search Orphan Drug Designations and Approvals
-
Generic Name: | L-citrulline |
---|---|
Date Designated: | 01/09/2017 |
Orphan Designation: | Prevention of clinical sequelae of acute lung injury induced by cardiopulmonary bypass in pediatric patients |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Asklepion Pharmaceuticals, LLC 729 East Pratt Street Suite 360 Baltimore, Maryland 21202 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-